11.1 C
Delhi
Saturday, January 17, 2026

Tag: innovative medicines

Sun Pharma Q2 Profit Rises 3% to ₹3,118 Crore, Beats Estimates

Sun Pharma reports strong Q2 results with 3% profit growth driven by India and emerging markets. Innovative medicines surpass generics in US for first time.

Sun Pharma Q2FY26 Net Profit Rises 2.5% to Rs 3,118 Crore

Sun Pharma reports 9% revenue growth in Q2FY26 with innovative US medicines surpassing generics for the first time. Strong EBITDA margin at 31.3%.